{"name":"Kiniksa Pharmaceuticals, Ltd.","slug":"kiniksa-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KPL-404","genericName":"KPL-404","slug":"kpl-404","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"KPL-404","genericName":"KPL-404","slug":"kpl-404","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1zNFBXNU94WEhVdWlaamhiVFNlc09qMEJwWkV2SmlkVEUyYmlXUlY0T0Z5OUhXdy1wUTk1Y290Zk4wQ1ZObzdrRUptVmZJNzZUU09HNnVUc1VJOWlCbTJFN1dJa0QyYnV1U1dwNEp3?oc=5","date":"2026-04-04","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Kiniksa Pharmaceuticals International, plc (KNSA) - Stock Titan","headline":"If You Invested $1,000 in Kiniksa Pharmaceuticals International, plc (KNSA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPSkJGNzEwbGxhdmhyRWR1ZkRPNFVwNE1udU1zazd2Q3ZWdHhheGNyWE91Y3FVNXVXQmVmdUN5VlI1VE9LU0JDMl9pRk5lX1JJLXd6UnROT2NlOUU3blg2WnVCMUJrWkZYX3NoQWQzTkU1Y01QZE9ERllyUFJPeFlDZHlYR0c3eGkwTkV1N3pqa2phejB3dF9yaUFlMl9NUmRBYVNFSl9lbGpOOXNkeDkwVlRIaVJLdw?oc=5","date":"2026-02-22","type":"pipeline","source":"AD HOC NEWS","summary":"Kiniksa (KNSA): Quiet Chart, Loud Pipeline — Is Wall Street Missing This? - AD HOC NEWS","headline":"Kiniksa (KNSA): Quiet Chart, Loud Pipeline — Is Wall Street Missing This?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPalU2aW00Y1JJRVhTQVE2ZnlzNTV1Vzk1U2tJaVVDUFdncVBjOTdqWE1LY1JJQ19IQjd1amtybnRZSHhwanRBcG1XeUtadm1NSnB6U29EMjlDTXBqenBRRVJLMG9mY2Y0b0gxSU5fLTdfVnVEN1dRTTRUZ3FZUm9yZ095bzNNU1pwWkpzeUo1Yw?oc=5","date":"2025-07-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Sanofi concludes Blueprint Medicines acquisition - Pharmaceutical Technology","headline":"Sanofi concludes Blueprint Medicines acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5peU90aHVUSVJBZllUZzJkWWZ6RGVHWElhakxuenhZcEFUOVFBdG1XNkc2Z1Y1bnQxU1kzU0F5RGZ1aExiS3BzeGc1dll6YVBlTjI4SDQ5U3JUeC1TYllVRWtQSmF5UG1iU2xyUUY3dm5ILWxlOEJGbmRWbUpudw?oc=5","date":"2025-07-01","type":"deal","source":"Investor's Business Daily","summary":"Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind - Investor's Business Daily","headline":"Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind - Invest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1pUGQ3YjRYYTdXZ3NTWDdLNlY0QVVKaGlYc3AzT2hwQ1FkSWlVRTRLR0FDZnAyQVZFakdSWUY2akp3bHozUXl0ZEdGSWxNOURZY2VZ?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"KNSA Stock Price, News & Analysis - Stock Titan","headline":"KNSA Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOZkNhSjJwaE1zbnpUaEVYSnhEZ3pDSk5aaWVOM01DVUprQTRSN0wwdEw2bElLMFdxTkNIRXQ0LWZLRVNOdHE4dHVZV0poLXI3OEp6Q2tORlBDNDhNbk8ybzVpcnVUUUV4Zkg0QTNXelJyekNXc3NLOTlfZ2U2eTNCWnlBWkpCanRMSkZiaWxJWWh0SFRCZ2E4?oc=5","date":"2025-03-02","type":"deal","source":"Yahoo Finance","summary":"Is Kiniksa Pharmaceuticals International, plc (KNSA) the Best Small Cap Pharma Stock to Buy Now? - Yahoo Finance","headline":"Is Kiniksa Pharmaceuticals International, plc (KNSA) the Best Small Cap Pharma Stock to Buy Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPdlhncUlBQW5sS01qeG96TTRPdmdubFBMRG1SQnY1ZnZOQjFhMjFld19ibGpXYXI3OVZRNlRLM0Z3Tlo1U0ozY1hHdmtWaWc5RW9iLWY4aVV5WGh6YmFwLWpOUEVON1dZeC04UHdfcTNNWmVkNEV6ZXBKZmFETG1SRklaaGo?oc=5","date":"2025-02-26","type":"pipeline","source":"The Pharma Letter","summary":"Kiniksa slims focus to cardiovascular diseases - The Pharma Letter","headline":"Kiniksa slims focus to cardiovascular diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOVVRjWlpsMVRSVzVzS0gxdXF3Um10M0pETDBLSUdoZXAxY2ZOd3FzRDhHMmJtSkdYR0M4NlY1dEtKYjloZm43OUNLa0Z4UndrSGhEdjg5eDUtMUxuSTJzdWh2UHVNN0hfOVY1LUdkNDl6WUdVdGZ5S3pUdVhxR1V5Q2xJbHpxTFVFalkwaEZJN190UExmdU83enJpSVY5Q0hhblpTYjdpUXRfU0lFTlNLVG82SGppVzdDVm8zUWd5RGVQdU9jU2FvV1lDQjM1dzlIdkpxMkJuTHY3eUJ6Y1I2WTVzaXQ3REZDVy04cEZfaUJCejdPck5pTTdqQ1ByRHRHRnA1SUxMTU5QQW5sRjI2eTZmVQ?oc=5","date":"2025-02-25","type":"pipeline","source":"GlobeNewswire","summary":"Kiniksa Pharmaceuticals Announces Development of KPL-387 in - GlobeNewswire","headline":"Kiniksa Pharmaceuticals Announces Development of KPL-387 in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5oWnYwMU51ZmhnQ2kxWm8yaGZLbU1wRnlBZnQwUlRLR1R1bmRWOWZaTl9Wc09NRXNMY1AwUlBsTWJvcUtBcEwyZnVEZlAtdnZqMHh2SXVsV3k5bWFwd2FQdjdGU21pT0hIeUNqZ25n0gFyQVVfeXFMTUVGN1UyQUdaZVBsMVdMQlRGZTVOeWt0VmpibE92V2VCT1RHa2FycGJKdUlmWlpXeGRsclZUM3k3MGFpclR0bXBsRlFXd28wZThmbm9scmFCSFpydFBEaEJqaXl4VnBDM3MxbXFUUE53b1VR?oc=5","date":"2024-06-25","type":"deal","source":"koreabiomed.com","summary":"Samsung Biologics inks $152 mil. deal with Kiniksa Pharmaceuticals - koreabiomed.com","headline":"Samsung Biologics inks $152 mil. deal with Kiniksa Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZ01vZGUxXzV5Q0xVOFdEakJOQVVKMDl2THJtZTNuUFZ5NC1Gc2piOHZ5SW1oRmtsSW5Mc0FBLS13SldwaUtVckx1b2J3Tkxtd1ZBZzRMNzdIUG84WFc1YkR2RnJsV29vWU9EUm5KV1NVQzVGNG9OLTlQOGllaTUyYkNRVE9nXy1xQlVGdUtKOFg0TjA?oc=5","date":"2022-08-03","type":"deal","source":"SEC.gov","summary":"Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab - SEC.gov","headline":"Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBjeW9zNndNU05OdnhQQVd3ZExEMUNSRlFOWXQ1Z19mUGhYQXUwMzlhdEQ1MGN0eXQ5ak1ndTVVUVZxbzBtb0tZR190alg1YXFs?oc=5","date":"2021-09-14","type":"pipeline","source":"The Motley Fool","summary":"Kiniksa Pharmaceuticals International, Plc - KNSA - Stock Price & News - The Motley Fool","headline":"Kiniksa Pharmaceuticals International, Plc - KNSA - Stock Price & News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNeDJlWVVmV29aZktrV3IteWF5eGdCXzFwcGxLcjVXRl8yR1RnMGNKb2dfQlJJSlRJWXZKd3FVMWhzMHVMdE84VVh0Um5ISlYzM2E3SlE0QUpsVkx1T3dMcUJrVVZZLVlTRkhUbXlVaXJDWnZ4RXFhcHRsbS1Sd05vbkJObGhFRmZtZTZpRGFNTU9nVllMWDN2Umk0cEhoU1lOc19nVmVyZm1YeGIzeDNQcDE1bGdZM0haMEE?oc=5","date":"2018-05-24","type":"pipeline","source":"Nasdaq","summary":"Nasdaq Welcomes Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA) to The Nasdaq Stock Market - Nasdaq","headline":"Nasdaq Welcomes Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA) to The Nasdaq Stock Market","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}